December 14, 2020
“Vertex Pharmaceuticals (VRTX)… Overall, it appears that Wall Street agrees with Tenthoff. VRTX shares have a Strong Buy analyst consensus rating, based on 14 Buys and 4 Holds. The stock’s $287.50 average price target suggests it has room for 24% growth… Continue Reading…
October 1, 2020
“When Jan Skvarka joined biotechnology firm Trillium Therapeutics Inc. as chief executive officer, he made a big bet to reshape the company and went all-in on a cancer treatment platform. Now, he’s reaping the rewards. It was the gamble of… Continue Reading…
June 8, 2020
“The Nasdaq Composite became the first of the three major averages to climb back to an all-time high, advancing 2.0%, or 198.27 points, to 9,814.08 on Friday and touching an intraday record of 9,845.69. After tumbling as much as 25% earlier this… Continue Reading…
May 18, 2020
“In our call of the day, Paul Schatz, the president of Heritage Capital, said the Dow DJIA, 3.39% could hit 30,000 points by 2021 and 40,000 by 2023 as the U.S. economy recovers over the longer term… “I firmly believe we will see Dow… Continue Reading…
March 24, 2020
“Activist investor Bill Ackman said he has made a “recovery bet” on the economy, investing $2.5 billion in equities, including upping his positions in several of his portfolio companies and reinvesting in others like Starbucks Corp… Ackman said his hedge… Continue Reading…
June 20, 2019
“Stocks rose sharply on Thursday after the Federal Reserve hinted at possible interest rate cuts as soon as next month. The S&P 500 surged 0.9%, hitting a record high of 2,954.33 as the tech and energy sectors outperformed. The Dow Jones Industrial Average gained 256 points… Continue Reading…
Recent Comments